Literature DB >> 34653753

The role of natural antioxidants in cisplatin-induced hepatotoxicity.

Norhashima Abd Rashid1, Syarifah Aisyah Syed Abd Halim2, Seong Lin Teoh3, Siti Balkis Budin4, Farida Hussan5, Nurul Raudzah Adib Ridzuan6, Nahdia Afiifah Abdul Jalil7.   

Abstract

Cisplatin is a potent platinum-based anticancer drug approved by the Food Drug Administration (FDA) in 1978. Despite its advantages against solid tumors, cisplatin confers toxicity to various tissues that limit its clinical uses. In cisplatin-induced hepatotoxicity, few mechanisms have been identified, which started as excess generation of reactive oxygen species that leads to oxidative stress, inflammation, DNA damage and apoptosis in the liver. Various natural products, plant extracts and oil rich in flavonoids, terpenoids, polyphenols, and phenolic acids were able to minimize oxidative stress by restoring the level of antioxidant enzymes and acting as an anti-inflammatory agent. Likewise, treatment with honey and royal jelly was demonstrated to decrease serum transaminases and scavenge free radicals in the liver after cisplatin administration. Medicinal properties of these natural products have a promising potential as a complementary therapy to counteract cisplatin-induced hepatotoxicity. This review concentrated on the protective role of several natural products, which has been proven in the laboratory findings to combat cisplatin-induced hepatotoxicity.
Copyright © 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Cisplatin; Complementary medicine; Herbs; Liver damage; Natural products

Mesh:

Substances:

Year:  2021        PMID: 34653753     DOI: 10.1016/j.biopha.2021.112328

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  7 in total

1.  Precise quantitative evaluation of pharmacokinetics of cisplatin using a radio-platinum tracer in tumor-bearing mice.

Authors:  Honoka Obata; Atsushi B Tsuji; Hitomi Sudo; Aya Sugyo; Katsuyuki Minegishi; Kotaro Nagatsu; Mikako Ogawa; Ming-Rong Zhang
Journal:  Nucl Med Commun       Date:  2022-09-19       Impact factor: 1.698

2.  Metabolic Profiling, Chemical Composition, Antioxidant Capacity, and In Vivo Hepato- and Nephroprotective Effects of Sonchus cornutus in Mice Exposed to Cisplatin.

Authors:  Sameh S Elhady; Reda F A Abdelhameed; Eman T Mehanna; Alaa Samir Wahba; Mahmoud A Elfaky; Abdulrahman E Koshak; Ahmad O Noor; Hanin A Bogari; Rania T Malatani; Marwa S Goda
Journal:  Antioxidants (Basel)       Date:  2022-04-22

Review 3.  The Regulatory Roles of Polysaccharides and Ferroptosis-Related Phytochemicals in Liver Diseases.

Authors:  Yijing Ren; Siyue Li; Zixuan Song; Qiuping Luo; Yingying Zhang; Hao Wang
Journal:  Nutrients       Date:  2022-05-30       Impact factor: 6.706

4.  Methanolic Phoenix dactylifera L. Extract Ameliorates Cisplatin-Induced Hepatic Injury in Male Rats.

Authors:  Heba Nageh Gad El-Hak; Hany Salah Mahmoud; Eman A Ahmed; Heba M Elnegris; Tahany Saleh Aldayel; Heba M A Abdelrazek; Mohamed T A Soliman; Menna Allah I El-Menyawy
Journal:  Nutrients       Date:  2022-02-28       Impact factor: 5.717

5.  A Comparison of XGBoost, Random Forest, and Nomograph for the Prediction of Disease Severity in Patients With COVID-19 Pneumonia: Implications of Cytokine and Immune Cell Profile.

Authors:  Wandong Hong; Xiaoying Zhou; Shengchun Jin; Yajing Lu; Jingyi Pan; Qingyi Lin; Shaopeng Yang; Tingting Xu; Zarrin Basharat; Maddalena Zippi; Sirio Fiorino; Vladislav Tsukanov; Simon Stock; Alfonso Grottesi; Qin Chen; Jingye Pan
Journal:  Front Cell Infect Microbiol       Date:  2022-04-12       Impact factor: 6.073

Review 6.  Hyperoside as a Potential Natural Product Targeting Oxidative Stress in Liver Diseases.

Authors:  Eungyeong Jang
Journal:  Antioxidants (Basel)       Date:  2022-07-25

Review 7.  Interactions of Analgesics with Cisplatin: Modulation of Anticancer Efficacy and Potential Organ Toxicity.

Authors:  Azza El-Sheikh; Zenat Khired
Journal:  Medicina (Kaunas)       Date:  2021-12-28       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.